Epo delivery by genetically engineered C2C12 myoblasts immobilized in microcapsules

Ainhoa Murua1, Gorka Orive, Rosa M Hernandez

  • 1Faculty of Pharmacy, Laboratory of Pharmacy and Pharmaceutical Technology, University of the Basque Country, Vitoria-Gasteiz, Spain.

Summary

Erythropoietin (Epo) is studied for cancer management. Beyond red blood cell production, its non-hematological effects and local tissue production are key for new therapeutic strategies.

Related Concept Videos